Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Data443 Risk Mitigation (ATDS) Liabilities and Shareholders Equity (2018 - 2025)

Data443 Risk Mitigation filings provide 7 years of Liabilities and Shareholders Equity readings, the most recent being $6.4 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 6.29% to $6.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.0 million, a 10.6% decrease, with the full-year FY2025 number at $6.4 million, up 6.29% from a year prior.
  • Liabilities and Shareholders Equity reached $6.4 million in Q4 2025 per ATDS's latest filing, up from $5.3 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $7.5 million in Q4 2023, with the low at $2.2 million in Q1 2022.
  • A 4-year average of $5.6 million and a median of $6.0 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Year-over-year, Liabilities and Shareholders Equity surged 78.18% in 2023 and then decreased 19.32% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $4.2 million in 2022, then soared by 78.18% to $7.5 million in 2023, then fell by 19.32% to $6.0 million in 2024, then increased by 6.29% to $6.4 million in 2025.
  • Per Business Quant, the three most recent readings for ATDS's Liabilities and Shareholders Equity are $6.4 million (Q4 2025), $5.3 million (Q3 2025), and $5.5 million (Q2 2025).